Since the beginnings of lumbar discectomy surgery, different types of synthetic and organic (sometimes autologous) materials and some drugs have been applied to the surgical area to act as a barrier to, or an inhibitor of, peridural fibrosis between the peridural space and the surrounding muscles. 1, 4, 7, 12, 14, 23, 24, 29 However, to date, no specific drug or barrier has been found that successfully prevents fibrosis after lumbar disc surgery.
As an alkylating antibiotic substance, mitomycin C is isolated from Streptomyces caespitosus. Its application on the surgical field has been shown to potentially suppress fibroblast proliferation. 8 Mitomycin C has been used for some time in glaucoma surgery to inhibit trabecular fibrosis and to treat tracheal fibrosis after tracheal reconstruction. The antifibrotic effects of mitomycin C also have been confirmed in different experimental laminectomy models in rats and rabbits. 5, 11, 15, 16, [18] [19] [20] 28, 29 The present study was designed to evaluate the effect of mitomycin C on peridural fibrosis in lumbar microdiscectomy.
Methods

Study Design
The ethics committee of Beyoglu Eye Research Hospital in Istanbul approved the study protocol. Two age-and sexmatched groups of patients were randomly selected and prospectively evaluated (Table 1) . Severe back and leg pain with different degrees of muscle weakness according to the level of herniation were exhibited in all patients. Patients included those who had not responded to longterm conservative medical treatment or to a physical therapy program. Preoperative diagnoses were made based on thin-sliced CT and MR images. Between April 2006 and December 2006, patients were randomized to receive either lumbar microdiscectomy or microdiscectomy with mitomycin C application. All patients were informed of the details regarding the type of operation, timing, difficulty, and potential complications of the topically applied drug. Written informed consent was obtained from all patients prior to the outset of the study; however, patients were not informed as to which group they would be placed. The surgeons who applied the drug and the 2 radiologists who evaluated the postoperative MR images were blinded to patients' names and which group the patients were in.
Randomization of Patients
Randomization was done by a clinical registered nurse who used a randomization chart that contained no information about the patients and surgeons. At the end of the operation, when the procedure had been completed and hemostasis had been ensured, the same nurse was called for the patient's assignment. In the drug group, an ophthalmological surgeon with no information about the patient was invited into the operating suite to apply the drug.
Operative Technique
All patients underwent surgery via a unilateral microdiscectomy approach. Briefly, after a control radiograph was obtained, a 2-cm skin incision was made. The paravertebral muscles were dissected with fine bone raspatories. A thin, self-retaining Gelpi retractor was used for surgical exposure. Under microscopic magnification (OPMI 6, Carl Zeiss Co.), both cranial and caudal laminotomies were performed using angled Kerrison rongeurs. The ligamentum flavum was excised. A discectomy was performed using straight and angled pituitary rongeurs. Strict bleeding control was performed at the end of the operation. Using a cotton ball, diluted mitomycin C (1 mg/ml) was applied to the discectomy orifice and inside the intervertebral space without touching the neural tissue. After 5 minutes, the surgical area was rinsed with physiological saline.
Exclusion Criteria
Patients were excluded if they had previously undergone spinal surgery, if they had been treated with epidural steroid drugs within 4 weeks of the proposed surgery, if they had been treated with oral steroid agents within 10 days of the surgery, or if they had received aspirin or other nonsteroidal antiinflammatory drugs within the 7 days preceding the surgery. Patients who had undergone myelography or lumbar puncture within 24 hours of the surgery also were excluded. All patients were evaluated before the surgery by an internal medicine specialist who performed physical and cardiological examinations, chest radiographs, and standard laboratory analyses including complete blood count, chemistry panel, hepatic and renal tests, and urinalysis. Patients with systemic illness, allergy, local/general infection, or slight anemia all were excluded from the study. To determine if there were any adverse effects of the drug, these same tests were done during the 1st week and the 1st month after surgery; no abnormality was found. Involvement in a workers' compensation claim was another criterion for exclusion. Patients were excluded intraoperatively if dural injury occurred.
Clinical Follow-Up
Preoperative and postoperative examinations were performed by the same neurologist in a blinded manner. The postoperative clinical follow-up examinations were performed during the 1st week, and then the 1st, 3rd, 6th, and 12th months. The LSOQ 23 and neurological examinations were used to evaluate the clinical outcomes of patients. Five composite scores were extrapolated from the patients' responses on the LSOQ. Lower-extremity weakness was evaluated as a motor scale from 0 (no motor weakness) to 5 (complete motor functional loss).
Leg Pain Severity Score. Patients used a 6-point scale to indicate the severity of their leg/buttock pain during the following times: 1) when it hurt the most; 2) when it hurt the least; 3) on average; 4) at the end of an active day; 5) on awakening; and 6) at the moment of responding to the questionnaire. Responses ranged from 1 (no pain) to 6 (maximum pain). Six values were obtained from each patient for all questions, and these scores were combined and rescaled to yield composite leg pain severity scores ranging from 0 to 100. Preoperatively, all patients had evidence of leg pain (score Ն 40) and/or lower-extremity weakness (score Ն 2).
Physical Symptoms and Radiculopathy Score. Using a 4-point scale (never, occasionally, frequently, and always) patients indicated how often they had experienced the following symptoms during the past week: 1) numbness or tingling in the lower extremities; 2) weakness in the lower extremities; 3) bowel or bladder dysfunction; and 4) trouble falling asleep or being awakened from sleep by pain. Answers were converted to the numeric values ranging from 1 (never) to 4 (always), and then calculated to yield a physical symptoms score from 0 to 100.
Functional Disability and Activity-Related Pain Scores.
Using a 4-point scale (all, most, some, and none), patients rated the degree to which they were able to perform each of 5 common activities of daily living, yielding 5 scores. They reported the number of days each month that they could not perform any of their usual work-related activities and the number of hours they spent during a day reclining, lying down, or sleeping, which yielded 2 additional scores. From a list we provided, they identified the daily activities that exacerbated their pain, yielding another score. The 8 scores thus obtained from each patient at each evaluation were combined and rescaled to yield a composite "functional disability with activity-related pain" score that ranged from 0 to 100. Radiological Follow-Up and Scores. All patients underwent follow-up contrast-enhanced MR imaging at 6 months after surgery. Peridural fibrosis was indicated by an iso-to hyperintense signal relative to the intervertebral discs on T1-weighted MR images obscuring the usual epidural fat signal intensity. Peridural fibrosis tends to form a curvilinear pattern surrounding the dural tube and is fairly homogeneous. The absence of mass effect is not an indicator for peridural fibrosis, however, given that both fibrosis and herniated discs may show mass effect. Retraction of the dural tube toward the side of the soft tissue is a criterion for fibrosis. 25, 26 Fibrotic tissue consistently enhances immediately after the injection of contrast material, regardless of the location of the fibrosis. Recurrent herniations tend to have a polypoid configuration, with a smooth outer margin. Recurrent disc material does not enhance within the first 10-20 minutes following the administration of contrast material. 26 Evaluations of control MR images were performed in a blinded manner by 2 neuroradiologists according to the grading system of Ross and associates. 25 The 5 contiguous axial slices centered around the surgically treated intervertebral disc were observed. Each of the 5 levels is further subdivided into 4 quadrants defined by perpendicular lines drawn from the central aspect of the thecal sac. Quadrants A and B are the right and left anterior epidural space, respectively, and encompass the lateral recesses and existing roots. Quadrants C and D are the right and left posterior epidural spaces, respectively. The posterior margin of the epidural evaluation site (at the laminotomy level) is defined by a line drawn between the posterior-most aspects of the remaining osseous lamina to exclude the scar along the more superficial operative tract. If the thecal sac is obscured by postoperative changes, then the quadrant lines are drawn from the expected central point of the thecal sac. For each imaging slice of the operative level, the amount of epidural fibrosis was graded on a scale of 0-4 with scores of 0 being no scar or trace of a scar, 1 being Ͼ 0% and Յ 25% of the quadrant filled with a scar, 2 being Ͼ 25% and Յ 50% of the quadrant filled with a scar, 3 being Ͼ 50% and Յ 75% of the quadrant filled with a scar, and 4 being Ͼ 75% and Յ 100% of the quadrant being filled with a scar (Figs. 1 and 2) . Therefore, 20 scores were obtained for each operative level encompassing the 5 imaging slices. The 2 radiologists independently evaluated 1200 quadrants of 5 slices in all 60 patients. The results were further compared and analyzed.
Statistical Analysis
Statistical analyses were performed using the t-test. Data are presented as means Ϯ SDs. Statistical significance was set at a probability value Ͻ 0.05. The power analysis of the statistical data was performed by software provided by Biostat Inc.
Results
All patients tolerated the surgical procedures well and had uneventful postoperative recoveries. There was no postoperative laboratory adverse effect as the result of drug usage. However, although intraoperative complications were not recorded, 1 patient in the drug group showed a small pseudomeningocele on postoperative MR imaging; the maximum diameter of the pseudomeningocele was 1 cm, and it was clinically silent. Therefore, reoperation was not required in this patient. This situation was initially thought to be a result of dural tissue damage from the intraoperative application of mitomycin C. However, peridural tissues were rinsed meticulously intraoperatively and the duration of time required for drug application was relatively short, and there was no contact with the dura mater. Moreover, the patient did not show any irregularity or delay with regard to healing of the surgical incision. Keeping all these factors of the patient in mind, we considered that the result should be noted as an unrecognized durotomy during surgery.
No patient underwent repeated surgery in either group for recurrent disc herniation or another indication; therefore, we had no opportunity to observe fibrosis or histopathological assessment after mitomycin application. Analysis of the MR images, including interpretations of enhancing and nonenhancing abnormalities, showed no significantly different results between patients in the treatment and control groups ( Table 2) . We did not observe any statistically significant between-group differences regarding the results of neurological examinations and LSOQ scores at each interval. The results of the LSOQ scores and neurological examina-tions are shown in Tables 3-6. The power analysis of MR imaging grading results of both groups yielded 48%. The leg pain severity and functional disability scores showed highest power in the 6th month (68 and 35%, respectively); physical symptoms and lower-extremity weakness scores showed highest power in the 90th day (20 and 90%, respectively).
Discussion
Peridural fibrosis has been a significant unsolved problem in the surgical treatment of lumbar disc herniation. It manifests in Ͼ 35% of failed-back surgery syndromes. 5, 6, 11, 15, 16, 22, 26, 29 Although there has been an increase in the number of experimental and clinical studies, no considerable progress has been made in treating peridural fibrosis to date. 1, 4, 7, 12, 23 The first studies concerning peridural fibrosis were conducted by Key and Ford. 10 In their preliminary experiments, they showed that destruction of the anulus fibrosis might be responsible for fibrous tissue formation and postoperative adhesions. Nachemson 21 was the second author to attempt to explain fibrotic changes according to pH measurements and tissue proton interactions. Other explanations for the origin of peridural fibrosis have been suggested (for example, foreign-body reactions to intraoperative debris, 9 a systemic fibrinolytic defect, 3 and a peridural hematoma in the path of the dissection 24 ); however, no consensus has been found thus far. Based on the popular theory of LaRocca and Macnab, 13 fibrosis is a laminectomy membrane caused and/or originated by damaged posterior spinal musculature. Migration of fibroblasts from the raw surface of the erector spinal muscles can cause postoperative scar tissue. 13 According to this theory, biological absorbable or nonbiological and inert materials implanted in the peridural space provide a barrier against advancing fibrotic tissue; the results of such barrier implantations have been varied.
Postoperative collection of a peridural hematoma may play an important role in dissecting peridural tissues and activating collagen by starting fibrotic processes in the cleavage of the operation area. However, strict consensus among spine surgeons exists regarding bleeding control after lumbar discectomy, and such bleeding control does not eliminate or decrease peridural fibrosis. Otherwise, the experiments have been performed in a rat model using a hemostyptic agent consisting of a collagen patch with a fixed layer of solid coagulation factors and did not show any benefit. 15 The unsuccessful results of using biologically inert barriers and antifibrinolytic drugs have led researchers to examine the intraoperative application of fibrosis-inhibiting agents. Given that peridural barriers have been unsuccessful, we believe that attempts to place a barrier, drugs, or antifibrosis agents should be made directly on the discectomy orifice to decrease strong fibrotic tissue organization of the anulus. 1, 4, 23, 27 Recently, a strong fibrosis inhibitor, an antiadhesion barrier gel (ADCON-L), was developed. It was incidentally discovered in glial cell cultures. In experimental studies and initial clinical applications, it has been shown to strongly decrease epidural fibrosis. 2, 17, 26 However, Richter and associates 24 failed to demonstrate any beneficial effect. Mitomycin C may suppress peridural fibrotic enlargement after lumbar disc surgery. It is an alkylating antibiotic agent isolated from S. caespitosus and is a well-known antitumor agent and a strong inhibitor of fibrosis both in vivo and in vitro. This inhibition has been shown in experimental studies of laminectomy models. 5, 15, 16, 29 Its effect is well known in other surgical fields. It has been used after glaucoma surgery to reduce fibrous tissue and provide passage of the trabecula. It also has been used topically in ear, nose, and throat surgery to provide patency of the trachea after a reconstructive anastomosis by reducing a tracheal cicatrix. 11, 19, 20, 28 In urology, submucosal injection of mito- mycin C significantly reduces recurrent urethral stricture after internal urethrotomy. 18 The drug is thought to inhibit RNA and protein synthesis via defects in DNA replication. 8 Topical application of mitomycin C is easily absorbed into cells by rapidly passing the cellular membrane in a few minutes. During surgery, it may be applied with a piece of cotton or a sponge. Application during surgery is ~ 2-5 minutes, and the dose ranges between 0.1 and 0.5 mg/ml. Some severe complications have been reported, including epithelial defects, scleral tissue loss, corneal perforation, keratitis, maculopathy, and delayed wound healing in ophthalmology surgery. All of these effects are attributable to the primary toxic effects of the drug on neighboring tissues. Based on previous clinical studies, we tried to yield the maximal effect from the drug using a 5-minute application of 1 mg/ml. 11, [18] [19] [20] 28 However, we avoided contact with neighboring tissues. After 5 minutes, all surgical areas were rinsed well.
Analyses of mitomycin C in our study failed to show a satisfactory clinical or radiological difference, although optimistic experimental studies have been performed. 5, 15, 16, 29 We believe that there are several important differences between experimental and clinical studies that may affect our expectations in clinical usage. The first of them is the lack of a true discectomy/disc rupture in experimental designs. Rupture or surgical damage of the anulus fibrosis may be a major initiating factor in peridural fibrosis in humans. Overloading of the human spine by walking after surgery also may initiate fibrotic changes in the laminotomy area. Otherwise, the measures of peridural fibrosis between animal
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Mitomycin in lumbar disc surgery 247 ); the clinical effects of mitomycin C might be better appreciated in procedures that involve substantially greater dural exposure such as multilevel laminectomies.
Conclusions
The insufficiency of any harmonic results regarding fibrosis inhibitors between experimental and clinical studies demonstrates the need for both comparable experimental models and multicenter clinical trials for the treatment of peridural fibrosis.
